Because of the high conservation across species, we examined whether polymorphism in these sequences might contribute to elevated Brn-3b expression in breast cancer biopsies by sequencing and comparing genomic DNA from 15 primary breast biopsies (including normal breast and breast cancer biopsies) with the breast cancer cell lines HB4a and MCF-7. The gene discussed is POU4F2; the disease is breast carcinoma.